Predicted LncRNA
Download
DataTables
LncRNA
Compound
Cancer
P-value
Effect
ENSG00000229702.1
ABT-263 (navitoclax)
Cervical squamouscell carcinoma and endocervical adenocarcinoma
0.034860858
Resistant
ENSG00000229702.1
ABT-263 (navitoclax)
Skin cutaneous melanoma
0.042803744
Resistant
